Design considerations for high throughput screening and in vitro diagnostic assays

Combinatorial Chemistry and High Throughput Screening

Volumn 10, Issue 6, 2007, Pages 399-412

  Achyuthan, Komandoor E ^a   Whitten, David G ^b  

^a SANDIA NATIONAL LABORATORIES   (United States)

^b MSC01 1070   (United States)

Author keywords

Assay development; Disease prevalence; High throughput screening (HTS); In vitro diagnostics (IVD); Quality control (QC); Receiver operating characteristic curve (ROC); Shelf life stability; Six sigma; Statistical tools

Indexed keywords

REAGENT;

BIOSENSOR; BIOTECHNOLOGY; BODY TEMPERATURE; COMBINATORIAL CHEMISTRY; CONFIDENCE INTERVAL; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FLUORESCENCE; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; ROBOTICS; ROC CURVE; STATISTICAL ANALYSIS;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; EQUIPMENT DESIGN; HUMANS; MASS SCREENING; STATISTICS AS TOPIC; TECHNOLOGY, PHARMACEUTICAL;

EID: 35448949421     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620707781996475     Document Type: Review

References (47)

1. Carter, J. M. "A guide to assay development", 2003, D&MD Report # 9114.
2. Gottlieb, S.; Woodcock, J. Nat. Biotechnol., 2006, 24, 927.
3. Abraham, V.C.; Taylor, D.L.; Hasking, J.R. Trends Biotechnol., 2004, 22, 15.
4. Manns, R. "Microplate History", 1999, 2nd Edition, presented at MipTec-ICAR'99; available from the Internet at: http://www.microplate.org/history/det_hist.htm [accessed: 4-30-2007].
5. Bersch, C. Medical Laboratory Observer, 2006, September, 16-22 (http://www.mlo-online.com); [accessed: 4-30-2007].
6. Watson, J.D.; Crick, F.H. Nature, 1953, 171, 737.
7. Mullis, K.B. Sci. Am., 1990, 262, 56 and 64.
8. Ma, H.; Horiuchi, K.Y. Drug Discov. Today, 2006, 11, 661.
9. "Human Genome Special Issue." Science, 2001, 291, 1145.
10. "The Human Genome." Nature, 2001, 409, 745.
11. Kramer, R.; Cohen, D. Nat. Rev. Drug Discov., 2004, 3, 965.
12. "SBS Recommended Microplate Specifications" Society of Biomolecular Sciences, 1999, available from the Internet at: www.sbsonline.org/msdc/pdf/text1999-05.pdf [accessed: 4-30-2007].
13. "Microplate Standards Working Group" Society of Biomolecular Sciences, 2004, available from the Internet at: http://www.sbsonline.org/ msdc/approved.php [accessed: 4-30-2007].
14. Weber, M.; Muthusubramaniam, L.; Murray, J.; Hudak, E.; Komienko, O.; Johnson, E.N.; Strulovici, B.; Kunapuli, P. Assay Drug Dev. Technol., 2007, 5, 117.
15. Janasek, D.; Franzke, J.; Manz, A. Nature, 2006, 442, 374.
16. "Engineering Statistics", NIST/SEMATECH e-Handbook of Statistical Methods, 2006, http://www.itl.nist.gov/div898/handbook/; [accessed: 4-30-2007].
17. Olderburg, K.R.; Zhang, J.-H.; Chen, T.; Maffia, A. III; Blom, K.F.; Combs, A.P.; Chung, T.D.Y. J. Biomol. Screen., 1998, 3, 55.
18. Whitesides, G.M. Nature, 2006, 442, 368.
19. "Statistical Guidance on Reporting Results from Studies Evaluating Diagnostics Tests: Draft Guidance for Industry and FDA Reviewers," FDA web site (Rockville, MD), 2003, available from the Internet at: www.fda.gov/cdrh/osb/guidance/1428.html. [accessed 4-30-2007].
20. "Medical Device Quality Systems Manual", U.S. Food and Drug Administration, 1997, available from the Internet at: http://www.fda.gov/cdrh/qsr/contnt.html [accessed 4-30-2007].
21. "The Top 15 IVD Companies Report", Medical Products Outsourcing, 2006, available from the Internet at: http://www.mpomag.com/ articles/2006/06/top-ivd-companies-report [accessed: 4-30-2007].
22. Pyzdek, T. Quality Engineering Handbook, CRC Press: Florida, 2003.
23. rd Edition, Wiley: New Jersey, 1977.
24. Gonick, L. and Smith, W. The Cartoon Guide to Statistics, 1993, Harper-Resource: New York, 1993.
25. nd Edition, McGraw-Hill: Indiana, 2003.
26. Orchard, T. BioPharm International, 2006, November, 34-46.
27. "Bioanalytical Method Validation: Guidance for Industry," US Department of Health and Human Services, 2001, available from the Internet at: www.fda.gov/cder/Guidance/4252fnl.pdf [accessed: 4-30-2007].
28. "Assay Guidance Manual" Version 4.1, Eli Lilly and Company and NIH Chemical Genomics Center, 2005, available from the Internet at: http://www.ncgc.nih.gov/guidance/manual_toc.html [accessed 4-30-2007].
29. Derzko, A.N. IVD Technology, 2005, March, 45-52.
30. Workman, J. Jr.; Mark, H. Spectroscopy, 2007, 22, 20.
31. nd edition, Chichester: England, 1988.
32. Elliott, S.; Sturman, B.; Anderson, S.; Brouwers, E.; Beijnen, J. Curr. Trends Mass Spectrom., 2007, April, 36-43.
33. Krull, I.; Swartz, M. LCGC, 1998, 16, 922.
34. Wang, H.; Subramanian, V.; Moorman, R.; Burleson, J.; Ko, J.; Johnson, D. LCGC, 1999, 17, 260.
35. Paino, T.C.; Moore, A.D. Pharmacol. Technol., 1999, October, 86-90.
36. Achyuthan, K.E. Luminescence, 2001, 16, 257.
37. Hamilton, M.S.; Abel, D.M.; Ballam, Y.J.; Otto, M.K.; Nickell, A.F.; Pence, L.M.; Appleman, J.R.; Shimasaki, C.D.; Achyuthan, K.E. J. Clin. Microbiol., 2002, 40, 2331.
38. Zweig, M.H.; Campbell, G. Clin. Chem., 1993, 39, 561.
39. Chen, D.; Ritchey, B.; Watson, A.; Gunn, H.; Young, J. BioPharm Intl., 2000, April, 48-50.
40. Fair, D.C. Quality Digest, 2007, April, 38-41.
41. "Title: 21Code of Federal Regulations (21 CFR Part 11), Electronic Records, Electronic Signatures," 2003, available from the Internet at: http://www.fda.gov/ora/compliance_ref/part11/ [accessed: 4-30-2007].
42. Benneyan, J.C.; Lloyd, R.C.; Plsek, P.E. Quality and Safety in Health Care, 2003, 12, 458.
43. Carroll, T.A.; Pinnick, H.A.; Carroll, W.E. Ann. Clin. Lab. Sci., 2003, 33, 113.
44. Zhang, J.H.; Chung, T.D.; Oldenburg, K.R. J. Biomol. Screen., 1999, 4, 67.
45. Robinson, K. BioPharm Intl., 2003, August, 38-46.
46. Lasky, F.D. Accreditation and Quality Assurance, 2001, 6, 415.
47. Malo, N.; Hanley, J.A.; Cerquozzi, S.; Pelletier, J.; Nadon, R. Nat. Biotechnol., 2006, 24, 167.